Price
$1.95
Decreased by -10.14%
Dollar volume (20D)
1.24 M
ADR%
19.49
Shares float
11.01 M
Shares short
4.18 K [0.04%]
Shares outstanding
36.19 M
Market cap
78.54 M
Beta
0.92
Price/earnings
N/A
20D range
1.17 2.72
50D range
0.90 2.72
200D range
0.90 2.96

Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide.

It develops its products using its proprietary bacteriophage-based technology.

The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia.

It has research collaboration agreement with Merck Sharp & Dohme Corp. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents.

The company is based in Los Angeles, California.

Armata Pharmaceuticals, Inc. operates as a subsidiary of Innoviva, Inc.

  • Quarterly earnings
  • Annual earnings
Reported date EPSChange YoY EstimateSurprise
May 5, 25 -0.20
Increased by +71.41%
-0.38
Increased by +48.08%
Mar 19, 25 -0.23
Increased by +57.87%
-0.35
Increased by +33.80%
Nov 12, 24 -0.15
Increased by +80.00%
-0.28
Increased by +46.43%
Aug 13, 24 0.25
Increased by +350.00%
-0.44
Increased by +156.82%
May 7, 24 -0.69
Decreased by -72.50%
-0.31
Decreased by -122.58%
Mar 21, 24 -0.55
Decreased by -89.66%
-0.35
Decreased by -57.14%
Nov 14, 23 -0.75
Decreased by -212.50%
-0.31
Decreased by -141.94%
Aug 14, 23 -0.10
Increased by +61.54%
-0.37
Increased by +72.97%
  • Quarterly financials
  • Annual financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Mar 31, 25 0.00
Decreased by -100.00%
-6.53 M
Increased by +73.90%
Decreased by N/A%
Decreased by N/A%
Dec 31, 24 1.24 M
Decreased by -19.18%
2.60 M
Increased by +113.10%
Increased by +210.53%
Increased by +116.21%
Sep 30, 24 0.00
Decreased by -100.00%
-5.48 M
Increased by +82.41%
Decreased by N/A%
Decreased by N/A%
Jun 30, 24 0.00
Decreased by -100.00%
8.99 M
Increased by +353.34%
Increased by +N/A%
Increased by +N/A%
Mar 31, 24 966.00 K
Increased by +21.36%
-25.02 M
Decreased by -41.89%
Decreased by -2.59 K%
Decreased by -16.92%
Dec 31, 23 1.53 M
Increased by +45.39%
-19.85 M
Decreased by -92.67%
Decreased by -1.30 K%
Decreased by -32.52%
Sep 30, 23 1.23 M
Decreased by -8.45%
-31.16 M
Decreased by -262.13%
Decreased by -2.54 K%
Decreased by -295.53%
Jun 30, 23 980.00 K
Decreased by -47.96%
-3.55 M
Increased by +61.49%
Decreased by -361.94%
Increased by +26.00%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY